Alessandro Tomelleri

About Alessandro Tomelleri

Alessandro Tomelleri, With an exceptional h-index of 25 and a recent h-index of 25 (since 2020), a distinguished researcher at Università Vita-Salute San Raffaele, specializes in the field of Rheumatology, Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort

The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort

Case report: Cytopenias in VEXAS syndrome-a WHO 2022 based approach in a single-center cohort

Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester …

Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica

Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry

Development of a diagnostic prediction model for giant cell arteritis by sequential application of Southend Giant Cell Arteritis Probability Score and ultrasonography: a …

Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease

Alessandro Tomelleri Information

University

Position

Vita-Salute San Raffaele University

Citations(all)

3435

Citations(since 2020)

3341

Cited By

1283

hIndex(all)

25

hIndex(since 2020)

25

i10Index(all)

46

i10Index(since 2020)

46

Email

University Profile Page

Google Scholar

Alessandro Tomelleri Skills & Research Interests

Rheumatology

Immunology

Top articles of Alessandro Tomelleri

Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort

American Journal of Hematology

2024/2

The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort

Rheumatology

2024/2/1

Alessandro Tomelleri
Alessandro Tomelleri

H-Index: 12

Case report: Cytopenias in VEXAS syndrome-a WHO 2022 based approach in a single-center cohort

Frontiers in Immunology

2024/1/25

Alessandro Tomelleri
Alessandro Tomelleri

H-Index: 12

Fabio Ciceri
Fabio Ciceri

H-Index: 29

Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester …

Journal of Neurology

2024/1

Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica

Rheumatology

2024/1/1

Alessandro Tomelleri
Alessandro Tomelleri

H-Index: 12

Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry

Seminars in Arthritis and Rheumatism

2024/6/1

Development of a diagnostic prediction model for giant cell arteritis by sequential application of Southend Giant Cell Arteritis Probability Score and ultrasonography: a …

The Lancet Rheumatology

2024/5/1

Alessandro Tomelleri
Alessandro Tomelleri

H-Index: 12

Bhaskar Dasgupta
Bhaskar Dasgupta

H-Index: 8

Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease

Rheumatology International

2024/3/20

Alessandro Tomelleri
Alessandro Tomelleri

H-Index: 12

Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica

Annals of the Rheumatic Diseases

2024/3/1

Alessandro Tomelleri
Alessandro Tomelleri

H-Index: 12

Effectiveness and safety of rituximab in Takayasu arteritis: a multicenter retrospective study

Joint bone spine

2024/3/1

Alessandro Tomelleri
Alessandro Tomelleri

H-Index: 12

Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir

Future Virology

2024/2

Alessandro Tomelleri
Alessandro Tomelleri

H-Index: 12

Fabio Ciceri
Fabio Ciceri

H-Index: 29

Paola Cinque
Paola Cinque

H-Index: 33

New blood biomarkers and imaging for disease stratification and monitoring of giant cell arteritis

RMD open

2024/2/1

Alessandro Tomelleri
Alessandro Tomelleri

H-Index: 12

Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies

Journal of Clinical Immunology

2024/2

Alessandro Tomelleri
Alessandro Tomelleri

H-Index: 12

Adult-onset Still’s disease complicated by Guillain-Barré syndrome

Rheumatology

2023/10/1

Alessandro Tomelleri
Alessandro Tomelleri

H-Index: 12

Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production

Rheumatology

2023/10/1

The provisional OMERACT ultrasonography score for giant cell arteritis

Annals of the rheumatic diseases

2023/4/1

Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?

2023/8/23

Alessandro Tomelleri
Alessandro Tomelleri

H-Index: 12

Bhaskar Dasgupta
Bhaskar Dasgupta

H-Index: 8

Efficacy of interleukin-1 blockade with anakinra in the management of post-COVID-19 steroid-dependent multisystem inflammatory syndrome: a case report

Scandinavian Journal of Rheumatology

2023/3/4

The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu Arteritis: A systematic review and meta-analysis

2023/3/1

See List of Professors in Alessandro Tomelleri University(Università Vita-Salute San Raffaele)